Related Experiment Video
Updated: Aug 11, 2026

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model
Published on: June 29, 2014
Comparison of cardiac function and valvular damage in children with and without adenotonsillar hypertrophy
Aysenur Pac1, Ahmet Karadag, Hanifi Kurtaran
1Fatih University Faculty of Medicine, Department of Pediatrics and Pediatric Cardiology, Ankara, Turkey.
Insights
Children with adenotonsillar hypertrophy showed shortened tricuspid end-diastolic time and potential silent carditis. Further research is needed to confirm the link between enlarged tonsils and cardiac dysfunction in pediatric patients.
Area of Science:
- Pediatric Cardiology
- Otorhinolaryngology
Background:
- Adenotonsillar hypertrophy is common in children.
- It can lead to various health issues, including potential cardiac complications.
Purpose of the Study:
- To compare cardiac function in children with and without adenotonsillar hypertrophy.
- To investigate the potential cardiac effects of adenotonsillar hypertrophy.
Main Methods:
- 28 children with adenotonsillar hypertrophy and 35 healthy controls were studied.
- Echocardiographic and electrocardiographic examinations were performed.
- Statistical analysis included chi-square and t-tests.
Main Results:
- Shortened tricuspid end-diastolic time was observed in children with adenotonsillar hypertrophy.
- Five patients with hypertrophy developed cardiac valve damage (silent carditis).
- No significant difference in right ventricular function was found between groups.
Conclusions:
- Adenotonsillar hypertrophy may be associated with shortened tricuspid end-diastolic time.
- Silent carditis is a potential complication in children with adenotonsillar hypertrophy.
- Further investigation into the link between tonsillar hypertrophy and cardiac dysfunction is warranted.
Objective:
Comparison of cardiac function in children with and without adenotonsillar hypertrophy.
Methods:
We examined 28 pediatric patients with adenotonsillar hypertrophy mean aged 7.3+/-2.9 years comprised of 14 females and 14 males (group I). The control group were chosen from 35 healthy sex and age matched children mean aged 7.37+/-2.7 years (group II). Both groups were examined by an otorhinolaryngologist and adenotonsillar hypertrophy was diagnosed with nasal endoscopic method or lateral neck X-ray. All the patients in group I underwent adenotonsillectomy. Cardiologic and echocardiographic examinations were performed in both groups. Echocardiographic examination was done twice in group I (preoperative and postoperative first month) however in group II only once. Preoperative findings of group I compared with the findings of group II. Preoperative and postoperative echocardiographic findings were also compared within group I. The chi-square test and the independent paired-sample t-test were used for statistical analysis.
Results:
The tricuspid end-diastolic time was the only significant difference in echocardiographic findings between the two groups (104.8+/-28.8 ms versus for 86.4+/-17.32 ms p<0.05). There was no statistical difference between preoperative and postoperative echocardiographic findings in group I. Brady-tachyarrhythmia was detected on electrocardiography - performed with 24h ambulatory electrocardiography - in one patient. To our surprise, in group I five patients had cardiac valve damage: mitral and/or aortic valve insufficiency. These findings were interpreted as silent carditis.
Conclusion:
There was no significant difference in right ventricular function between the children with and without adenotonsillar hypertrophy. Whereas, there was shortening of tricuspid end-diastolic time in group I. However, five patients having adenotonsillar hypertrophy developed a cardiac dysfunction which was not observed in the control group. Therefore, we assumed a correlation between adenotonsillar hypertrophy and possible silent carditis following frequent tonsillitis.
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy

